Evaluation of inflammation and oxidative stress in ankylosing spondylitis: A role for macrophage migration inhibitory factor

Modern Rheumatology

Volumn 20, Issue 1, 2010, Pages 34-39

  Kozaci, Leyla Didem ^a   Sari, Ismail ^b   Alacacioglu, Ahmet ^b   Akar, Servet ^b   Akkoc, Nurullah ^b  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Ankylosing spondylitis; Interleukin 10; Macrophage migration inhibitory factor (MIF); Oxidative stress

Indexed keywords

GLUCOSE; INTERLEUKIN 10; LIPID; MACROPHAGE MIGRATION INHIBITION FACTOR; MALONALDEHYDE; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ACUTE DISEASE; ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE MARKER; EARLY INTERVENTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; MALE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN TARGETING; SPINE MOBILITY;

ACUTE-PHASE PROTEINS; ADULT; BLOOD GLUCOSE; FEMALE; HUMANS; INTERLEUKIN-10; INTRAMOLECULAR OXIDOREDUCTASES; LIPIDS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MALONDIALDEHYDE; NITRIC OXIDE; OXIDATIVE STRESS; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING;

EID: 76649094570     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-009-0230-9     Document Type: Article

References (38)

1. van der Linden S, van der Heijde D. Ankylosing spondylitis. Clinical features. Rheum Dis Clin North Am. 1998;24:663-76.
2. MA Khan EJ Ball 2002 Genetic aspects of ankylosing spondylitis Best Pract Res Clin Rheumatol 16 675 690 1:CAS:528:DC%2BD3sXhtVynsbY%3D 12406434
3. J Braun Z Yin I Spiller S Siegert M Rudwaleit L Liu, et al. 1999 Low secretion of tumor necrosis factor alpha, but no other Th1 or Th2 cytokines, by peripheral blood mononuclear cells correlates with chronicity in reactive arthritis Arthritis Rheum 42 2039 2044 10.1002/1529-0131(199910)42:10<2039:: AID-ANR3>3.0.CO;2-6 1:CAS:528:DyaK1MXmvV2ksrg%3D 10524674 (Pubitemid 30263586)
4. T Calandra T Roger 2003 Macrophage migration inhibitory factor: a regulator of innate immunity Nat Rev Immunol 3 791 800 10.1038/nri1200 1:CAS:528:DC%2BD3sXntlWnsLY%3D 14502271 (Pubitemid 37328657)
5. A Pakozdi MA Amin CS Haas RJ Martinez GK Haines 3rd LL Santos, et al. 2006 Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritis Arthritis Res Ther 8 R132 10.1186/ar2021 16872482
6. A Martinez G Orozco J Varade M Sanchez Lopez D Pascual A Balsa, et al. 2007 Macrophage migration inhibitory factor gene: influence on rheumatoid arthritis susceptibility Hum Immunol 68 744 747 10.1016/j.humimm.2007.06.007 1:CAS:528:DC%2BD2sXhtVeru7vP 17869648 (Pubitemid 47379983)
7. P Willeke M Gaubitz H Schotte C Maaser W Domschke B Schluter, et al. 2007 Increased serum levels of macrophage migration inhibitory factor in patients with primary Sjogren's syndrome Arthritis Res Ther 9 R43 10.1186/ar2182 17470266 (Pubitemid 46812965)
8. A Foote EM Briganti Y Kipen L Santos M Leech EF Morand 2004 Macrophage migration inhibitory factor in systemic lupus erythematosus J Rheumatol 31 268 273 1:CAS:528:DC%2BD2cXhslehtbs%3D 14760795 (Pubitemid 38160747)
9. YQ Zou LJ Lu SJ Li T Zeng XD Wang CD Bao, et al. 2008 The levels of macrophage migration inhibitory factor as an indicator of disease activity and severity in adult-onset Still's disease Clin Biochem 41 519 524 10.1016/j.clinbiochem.2008.01.008 1:CAS:528:DC%2BD1cXks12itLw%3D 18261992
10. TT Antoniv LB Ivashkiv 2006 Dysregulation of interleukin-10-dependent gene expression in rheumatoid arthritis synovial macrophages Arthritis Rheum 54 2711 2721 10.1002/art.22055 1:CAS:528:DC%2BD28XhtFWksLvE 16947381 (Pubitemid 44497750)
11. J Wu FQ Cunha FY Liew WY Weiser 1993 IL-10 inhibits the synthesis of migration inhibitory factor and migration inhibitory factor-mediated macrophage activation J Immunol 151 4325 4332 1:CAS:528:DyaK2cXmsFCi 7691945
12. M Karakoc O Altindag H Keles N Soran S Selek 2007 Serum oxidative-antioxidative status in patients with ankylosing spondylitis Rheumatol Int 27 1131 1134 10.1007/s00296-007-0352-3 1:CAS:528:DC%2BD2sXhtVSisLbL 17443328 (Pubitemid 47373938)
13. S Ozgocmen S Sogut O Ardicoglu E Fadillioglu I Pekkutucu O Akyol 2004 Serum nitric oxide, catalase, superoxide dismutase, and malondialdehyde status in patients with ankylosing spondylitis Rheumatol Int 24 80 83 10.1007/s00296-003-0335-y 1:CAS:528:DC%2BD2cXhsl2gt7g%3D 12811507 (Pubitemid 38388749)
14. C Yazici K Kose M Calis S Kuzuguden M Kirnap 2004 Protein oxidation status in patients with ankylosing spondylitis Rheumatology (Oxford) 43 1235 1239 10.1093/rheumatology/keh317 1:CAS:528:DC%2BD2cXnvVOqsrw%3D (Pubitemid 39359296)
15. JW Horton 2003 Free radicals and lipid peroxidation mediated injury in burn trauma: the role of antioxidant therapy Toxicology 189 75 88 10.1016/S0300-483X(03)00154-9 1:CAS:528:DC%2BD3sXkvVCmt7o%3D 12821284 (Pubitemid 36725024)
16. A LeGrand B Fermor C Fink DS Pisetsky JB Weinberg TP Vail, et al. 2001 Interleukin-1, tumor necrosis factor alpha, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E2 production in explants of human osteoarthritic knee menisci Arthritis Rheum 44 2078 2083 10.1002/1529- 0131(200109)44:9<2078::AID-ART358>3.0.CO;2-J 1:CAS:528: DC%2BD3MXpt12ltrs%3D 11592370 (Pubitemid 33644051)
17. S Stosic-Grujicic I Stojanovic D Maksimovic-Ivanic M Momcilovic D Popadic L Harhaji, et al. 2008 Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus J Cell Physiol 215 665 675 10.1002/jcp.21346 1:CAS:528:DC%2BD1cXlvVKgtL0%3D 18064633 (Pubitemid 351632688)
18. D Jang GA Murrell 1998 Nitric oxide in arthritis Free Radic Biol Med 24 1511 1519 10.1016/S0891-5849(97)00459-0 1:CAS:528:DyaK1cXjvVGgu7g%3D 9641270 (Pubitemid 28270354)
19. S Roberts RC Butler 2005 Inflammatory mediators as potential therapeutic targets in the spine Curr Drug Targets Inflamm Allergy 4 257 266 10.2174/1568010053586372 1:CAS:528:DC%2BD2MXlsFelsbc%3D 15853748 (Pubitemid 40873108)
20. TN Pham P Rahman YM Tobin MM Khraishi SF Hamilton C Alderdice, et al. 2003 Elevated serum nitric oxide levels in patients with inflammatory arthritis associated with co-expression of inducible nitric oxide synthase and protein kinase C-eta in peripheral blood monocyte-derived macrophages J Rheumatol 30 2529 2534 1:CAS:528:DC%2BD2cXktVCgtL4%3D 14719189
21. PT Yang H Kasai LJ Zhao WG Xiao F Tanabe M Ito 2004 Increased CCR4 expression on circulating CD4(+) T cells in ankylosing spondylitis, rheumatoid arthritis and systemic lupus erythematosus Clin Exp Immunol 138 342 347 10.1111/j.1365-2249.2004.02617.x 1:CAS:528:DC%2BD2cXhtVaksbjM 15498047 (Pubitemid 39472454)
22. S van der Linden HA Valkenburg A Cats 1984 Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria Arthritis Rheum 27 361 368 10.1002/art.1780270401 6231933
23. T Yoshioka K Kawada T Shimada M Mori 1979 Lipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygen toxicity in the blood Am J Obstet Gynecol 135 372 376 1:CAS:528:DyaL3cXjslKl 484629
24. JA Navarro-Gonzalvez C Garcia-Benayas J Arenas 1998 Semiautomated measurement of nitrate in biological fluids Clin Chem 44 679 681 1:CAS:528:DyaK1cXhslSrsrY%3D 9510886
25. TR Jenkinson PA Mallorie HC Whitelock LG Kennedy SL Garrett A Calin 1994 Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index J Rheumatol 21 1694 1698 1:STN:280:DyaK2M%2Fpslaquw%3D%3D 7799351
26. A Calin S Garrett H Whitelock LG Kennedy J O'Hea P Mallorie, et al. 1994 A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index J Rheumatol 21 2281 2285 1:STN:280:DyaK2M3htl2qsA%3D%3D 7699629
27. S Garrett T Jenkinson LG Kennedy H Whitelock P Gaisford A Calin 1994 A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index J Rheumatol 21 2286 2291 1:STN:280:DyaK2M3htl2qsQ%3D%3D 7699630
28. I Stojanovic T Cvjeticanin S Lazaroski S Stosic-Grujicic D Miljkovic 2009 Macrophage migration inhibitory factor stimulates interleukin-17 expression and production in lymph node cells Immunology 126 74 83 10.1111/j.1365-2567.2008. 02879.x 1:CAS:528:DC%2BD1MXptFehtw%3D%3D 18624729
29. D Aeberli M Leech EF Morand 2006 Macrophage migration inhibitory factor and glucocorticoid sensitivity Rheumatology (Oxford) 45 937 943 10.1093/rheumatology/kel142 1:CAS:528:DC%2BD28Xotl2rsr8%3D (Pubitemid 44283046)
30. D Aeberli Y Yang A Mansell L Santos M Leech EF Morand 2006 Endogenous macrophage migration inhibitory factor modulates glucocorticoid sensitivity in macrophages via effects on MAP kinase phosphatase-1 and p38 MAP kinase FEBS Lett 580 974 981 10.1016/j.febslet.2006.01.027 1:CAS:528:DC%2BD28XhtFejt7o%3D 16442105 (Pubitemid 43152322)
31. CT Chou AP Huo HN Chang CY Tsai WS Chen HP Wang 2007 Cytokine production from peripheral blood mononuclear cells in patients with ankylosing spondylitis and their first-degree relatives Arch Med Res 38 190 195 10.1016/j.arcmed.2006. 09.008 1:CAS:528:DC%2BD2sXkvFClsA%3D%3D 17227728 (Pubitemid 46080541)
32. V Goedecke AM Crane E Jaakkola W Kaluza K Laiho DE Weeks, et al. 2003 Interleukin 10 polymorphisms in ankylosing spondylitis Genes Immun 4 74 76 10.1038/sj.gene.6363930 1:CAS:528:DC%2BD3sXhsVCmurY%3D 12595905 (Pubitemid 38967577)
33. Reikeras O, Helle A, Krohn CD, Brox JI. Systemic and local cytokine kinetics in musculoskeletal injury: a prospective study in patients with ankylosing spondylitis. Scand J Clin Lab Invest. 2008;22:1-6.
34. AB Stavitsky J Xianli 2002 In vitro and in vivo regulation by macrophage migration inhibitory factor (MIF) of expression of MHC-II, costimulatory, adhesion, receptor, and cytokine molecules Cell Immunol 217 95 104 10.1016/S0008-8749(02)00516-6 1:CAS:528:DC%2BD38XosVers7c%3D 12426005 (Pubitemid 35352164)
35. MM Vazquez-Del A Garcia-Gonzalez JF Munoz-Valle T Garcia-Iglesias G Martinez-Bonilla G Bernard-Medina, et al. 2002 Interleukin 1beta (IL-1beta), IL-10, tumor necrosis factor-alpha, and cellular proliferation index in peripheral blood mononuclear cells in patients with ankylosing spondylitis J Rheumatol 29 522 526
36. TR Radstake FC Sweep P Welsing B Franke SH Vermeulen A Geurts-Moespot, et al. 2005 Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor Arthritis Rheum 52 3020 3029 10.1002/art.21285 1:CAS:528: DC%2BD2MXhtF2msrrM 16200611 (Pubitemid 41447081)
37. EF Morand 2005 New therapeutic target in inflammatory disease: macrophage migration inhibitory factor Intern Med J 35 419 426 10.1111/j.1445-5994.2005. 00853.x 1:CAS:528:DC%2BD2MXps1Kku70%3D 15958113 (Pubitemid 40917441)
38. D Biasi A Carletto P Caramaschi P Bellavite G Andrioli M Caraffi, et al. 1995 Neutrophil functions, spondylarthropathies and HLA-B27: a study of 43 patients Clin Exp Rheumatol 13 623 627 1:STN:280:DyaK287islejug%3D%3D 8575141